|
||||||||||||||||||
|
|
||||||||||||||||||
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Questions? Please consult our answers to frequently asked questions at http://www.ebioscience.com/faq. DescriptionThe HIT2 monoclonal antibody reacts with the human CD38 molecule, an approximately 45 kDa type II transmembrane protein. CD38 is expressed by thymocytes, peripheral B cells including plasma cells, activated T cells, and monocytes. CD38 is a counter-receptor for CD31 and has both cyclase and hydrolase enzymatic activity. Applications ReportedFor research use only, not for diagnostic or therapeutic use. The HIT2 antibody has been reported for use in flow cytometric analysis. Applications TestedThe HIT2 antibody has been pre-titrated and tested by flow cytometric analysis of human peripheral blood leukocytes. This can be used at 20 μl (0.25 μg) per 100 μl blood (or per 1 million cells in 100 μl total staining volume). References
McMichael, A.J., P.C.L. Beverly, et al. eds. (1987). Leucocyte Typing III: White Cell Differentiation Antigens. Oxford University Press. New York. Joshua, D., A. Petersen, et al. (1996). "The labelling index of primitive plasma cells determines the clinical behaviour of patients with myelomatosis." Br J Haematol 94(1): 76-81. Horenstein, A. L., H. Stockinger, et al. (1998). "CD38 binding to human myeloid cells is mediated by mouse and human CD31." Biochem J 330(Pt 3): 1129-35. Deaglio, S., M. Morra, et al. (1998). "Human CD38 (ADP-ribosyl cyclase) is a counter-receptor of CD31, an Ig superfamily member." J Immunol 160(1): 395-402. Related ProductsCat. 12-4714 Phycoerythrin (PE) Mouse IgG1, K Isotype Control |
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
![]() |
![]() |
|
Copyright © 2000-2008 eBioscience, Inc. Product For Research Use Only: Not for further distribution without written consent. |